Press Releases
11 November 2019
WARSAW, Ind., Nov. 11, 2019 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, will participate in the Piper Jaffray Annual Healthcare Conference at the Lotte New York Palace in New York City. Bryan Hanson, President and Chief Executive Officer and
Read more...AUSTIN, Texas, Nov. 11, 2019 /PRNewswire/ -- Patients, health care providers and local communities will come together the week of November 10 to celebrate National Nurse Practitioner Week, the annual recognition of the vital contributions of nurse practitioners (NPs) nationwide. For more than 50 years, NPs have championed the needs of p
Read more...LAVAL, Quebec, Nov. 11, 2019 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) today announced that the Company will participate in three investor conferences.Joseph C. Papa, chairman and chief executive officer, Sam Eldessouky, senior vice president and corporate controller, and
Read more...11 November 2019
Revenues increase 49% sequentially over Q1 results Increasing focus on U.S. B2C strategy supported by the IFF partnership LAVAL, QC, Nov. 11, 2019 /PRNewswire/ - Neptune Wellness Solutions Inc. ("Neptune" or the "Corporation") (NASDAQ: NEPT) (TSX: NEPT), today announced its financial and operating results for the three-
Read more...SALT LAKE CITY, Nov. 11, 2019 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company, announced today that it has received a Complete Response Letter ("CRL") from the United States Food and Drug Administration ("FDA") regarding its New Drug Application ("NDA") for TLANDO™, the Company's oral testosterone product candidate for
Read more...11 November 2019
HONG KONG, Nov. 11, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced the appointment of a new independent non-executive director to the Board
Read more...NASHVILLE, Tenn., Nov. 11, 2019 /PRNewswire/ -- Patriot Angels CEO Suzette Graham celebrates Veterans Day by announcing on Mike
Read more...11 November 2019
Partnership to accelerate Neptune's entry into the B2C market with the Forest Remedies brand
Read more...SANTA MONICA, Calif., Nov. 11, 2019 /PRNewswire/ -- PatientPop, the healthcare leader in practice growth technology, was ranked 3
Read more...11 November 2019
NATIONAL HARBOR, Md., Nov. 11, 2019 /PRNewswire/ -- Akeso Biopharma ("Akeso") presented results of phase 1 study of its first-in-class bispecific drug candidate AK104, in patients with advanced solid tumors in 2019 Society for Immunotherapy of Cancer ("SITC"). AK104 is a novel, tetrameric bispecific antibody targeting both PD-1 and CTLA-4. Dr. Ben Markman
Read more...
